Enjoy complimentary customisation on priority with our Enterprise License!
The extracorporeal membrane oxygenation machines market size is forecast to increase by USD 145.04 million at a CAGR of 5.92% between 2023 and 2028. Market growth hinges on several key factors, notably the escalating prevalence of respiratory and heart failure cases. This trend is paralleled by a surge in new product launches, introducing innovative solutions to address medical challenges. Additionally, the rise in organ transplant procedures further propels market expansion, reflecting advancements in healthcare technologies and treatment options. These factors collectively underscore a dynamic landscape characterized by increased demand for medical interventions and therapies. However, challenges such as regulatory compliance and healthcare infrastructure constraints may impact market dynamics. Nonetheless, the market's trajectory remains optimistic, driven by continuous advancements and a growing focus on addressing critical health concerns.
To learn more about this report, Download Report Sample
The market is driven by critical factors such as the prevalence of cardio-pulmonary disorders and continuous product innovations and technological advancements. Industry giants like Medtronic and Braile Biomedica lead with cutting-edge Algorithms and advanced systems like the Liby System, catering to conditions like Coronary heart diseases and Strokes. However, challenges such as stringent regulatory policies and complexities in handling blood interactions, including managing carbon dioxide levels and delivering oxygen-filled blood, pose notable obstacles. Understanding market dynamics like customer and company landscape and navigating promotional activities are key to overcoming these challenges and capitalizing on emerging major trends.
The increasing incidence of respiratory and heart failure is notably driving the market. The increasing prevalence of various chronic cardiovascular diseases (CVD) and respiratory diseases leads to a rise in the number of deaths. Patients with chronic CVD and respiratory diseases have a high risk of developing respiratory or cardiac failure. Extracorporeal membrane oxygenation machines are used as life-support devices or machines for the treatment of patients with chronic cardiovascular and respiratory diseases.
The prevalence of CVDs and other heart diseases has increased significantly across the world. Ischemic heart disease, coronary artery disease, and myocardial infarctions are some of the major heart diseases that affect the population. Extracorporeal membrane oxygenation machines minimize the chances of cardiac failure in people with chronic cardiovascular disease. This is expected to fuel the global market during the forecast period.
Technological advancements in ECMO machines is a primary trend in the market. The market is a dynamic arena influenced by various factors. Key considerations include cardio-pulmonary disorders and the continuous drive for product innovations and technological advancements. Regulatory frameworks also play a pivotal role in shaping the landscape of ECMO technologies. In the realm of medical devices, factors such as the interaction of blood with ECMO systems, the functionality of heart-lung machines, and the exchange of carbon dioxide for oxygen-filled blood are paramount.
These machines are essential for treating Cardiopulmonary disease and managing Respiratory failure in critical patients. Companies like Medtronic and Braile Biomedica are significant players, leveraging algorithms and innovative systems like the Liby System to address conditions such as Coronary heart diseases and Strokes. Diverse Pumps including Roller pumps contribute to the efficacy of ECMO therapy. This is expected to fuel the global market during the forecast period.
High costs associated with cardiac and respiratory procedures is a major challeneg hindering the market. Extracorporeal Membrane Oxygenation (ECMO) machines play a crucial role in addressing cardio-pulmonary disorders, particularly during heart and lung transplant surgeries and in managing cardiogenic shock and respiratory failures. These machines have gained significant traction among healthcare providers due to the increasing prevalence of chronic diseases, such as coronary heart diseases and strokes.
Moreover, product innovations and technological advancements have expanded the capabilities of ECMO systems, enabling them to effectively treat various cardiovascular conditions, including hypothermic cardiocirculatory arrest. ECMO machines function as heart-lung machines, circulating oxygen-filled blood through the body while removing carbon dioxide. The blood is passed through a membrane, which separates the gases, ensuring adequate oxygenation and carbon dioxide removal for the tissues. Hence, such factors are hindering the market during the forecast period.
The veno-venous and arterio-venous segment showed a gradual increase in the market share of USD 226.29 million in 2018. The increasing prevalence of various chronic respiratory diseases, high incidence of respiratory failures, the growing cases of lung transplants, and increasing technological advances are the major factors contributing to the growth of the veno-venous and arterio-venous extracorporeal membrane oxygenation machines segment of the global market during the forecast period.
To understand geographic trends Download Report Sample
North America is estimated to contribute 36% to the growth of the global market during the forecast period. The market in the region is mainly driven by the increasing prevalence of cardiovascular and respiratory diseases, the increasing number of lung and heart transplant procedures, the rising adoption of technologically advanced medical devices, increasing awareness among healthcare professionals about the benefits of the extracorporeal membrane oxygenation process, and increasing healthcare expenditure. In addition, the growing presence of companies that manufacture extracorporeal membrane oxygenation machines and increasing technological advances in extracorporeal membrane oxygenation procedures are driving the market in North America during the forecast period.
The Market is fragmented in nature. Some significant players include Abbott Laboratories, Abiomed Inc., Braile Biomedica, Chalice Medical Ltd and CytoSorbents Europe GmbH.
The research report also includes detailed analyses of the competitive landscape of the market and information about 15 market companies, including:
Eurosets Srl, Fresenius Medical Care AG and Co. KGaA, Getinge AB, LivaNova Plc, MC3 Cardiopulmonary, Medtronic Plc, MicroPort Scientific Corp., Nipro Corp., OriGen Biomedical Inc., Palex Medical SA, Sechrist Industries Inc., Senko Medical Industry Co. Ltd., Spectrum Medical Ltd., Terumo Corp., and Xenios AG
The market research report provides comprehensive data (region wise segment analysis), with forecasts and estimates in "USD Million" for the period 2023 to 2028, as well as historical data from 2018 to 2022 for the following segments.
You may also interested in below market reports:
Oxygenators Market: Logistics Services Software Market Analysis North America, Europe, APAC, Middle East and Africa, South America - US, China, Japan, Germany, UK - Size and Forecast
Apheresis Devices Market: Apheresis Devices Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Canada, Germany, UK, China - Size and Forecast
Heart-lung Machines Market: Heart-lung Machines Market by End-user, Application and Geography - Forecast and Analysis
The Market is witnessing significant growth driven by several key factors. First, the rising incidence of cardio-pulmonary disorders necessitates advanced medical solutions like ECMO machines. Second, continuous product innovations and technological advancements in ECMO technology enhance patient outcomes and treatment effectiveness. Moreover, regulatory policies play a crucial role in shaping market dynamics and ensuring product safety and efficacy. ECMO machines function by oxygenating blood outside the body, particularly in cases of severe respiratory or heart lung machine failure. This process involves removing carbon dioxide and infusing oxygen-filled blood back into the patient's tissues via the lungs.
However, challenges such as condemnatory care conditions and potential risks like pump head thrombosis or mechanical failure underscore the need for continuous medical processes and improvements in ECMO technology. The market caters to diverse patient types, including infants and adults, with specialized ECMO systems like Veno-Venous ECMO and Veno-Arterial ECMO. Major trends in the ECMO market include advancements in Artificial Intelligence integration, development of biocompatible materials, and increased focus on patient safety and quality control. Additionally, hospital acquisitions, global market trends, and ongoing clinical trials contribute to a dynamic landscape for ECMO machines, supporting critical care capabilities and enhancing healthcare economics.
Furthermore, the Market is propelled by numerous key factors. These include the need for sustaining instrument for critical patients, the complex tension involved in managing severe cases, and the vital role ECMO plays in life-saving surgery within healthcare facilities. Challenges such as acute oxygenator thrombosis and the critical role of the impeller in ECMO machines are addressed through continuous advancements and algorithms guiding treatment protocols. ECMO machines are indispensable in managing conditions like Cardiopulmonary disease and Respiratory failure, especially in cases of Coronary heart diseases or Strokes. Innovations such as the Liby System and various types of Pumps including Roller and Centrifugal pumps enhance cardiac disorder management and patient outcomes.
Market Scope |
|
Report Coverage |
Details |
Page number |
168 |
Base year |
2023 |
Historic period |
2018 - 2022 |
Forecast period |
2024-2028 |
Growth momentum & CAGR |
Accelerate at a CAGR of 5.92% |
Market growth 2024-2028 |
USD 145.04 million |
Market structure |
Fragmented |
YoY growth 2023-2024(%) |
5.35 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 36% |
Key countries |
US, Canada, Germany, UK, and China |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Key companies profiled |
Abbott Laboratories, Braile Biomedica, Chalice Medical Ltd., CytoSorbents Corp., Edwards Lifesciences Corp., Eurosets Srl, Fresenius SE and Co. KGaA, Gen World Medical Devices, Getinge AB, Johnson and Johnson Services Inc., LivaNova PLC, MC3 Cardiopulmonary, Medtronic, MicroPort Scientific Corp., Nipro Corp., OriGen Biomedical Inc., Sechrist Industries Inc., Senko Medical Instrument Mfg. Co. Ltd., Spectrum Medical Ltd., and Terumo Corp. |
Market dynamics |
Parent market analysis, market forecasting growth analysis, market research and growth, Market forecasting, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, Market growth and Forecasting, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period |
Customization purview |
If our market report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this market research report to meet your requirements.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Modality
7 Market Segmentation by Product
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.